Singapore markets closed

Sesen Bio, Inc. (SESN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.5252+0.0029 (+0.56%)
At close: 04:00PM EDT
0.5310 +0.01 (+1.10%)
After hours: 07:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 102.28M
Enterprise value -67.51M
Trailing P/E 1.49
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)4.45
Price/book (mrq)0.59
Enterprise value/revenue -3.04
Enterprise value/EBITDA 1.94

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-86.43%
S&P500 52-week change 3-1.04%
52-week high 36.0400
52-week low 30.3650
50-day moving average 30.5300
200-day moving average 30.8084

Share statistics

Avg vol (3-month) 33.93M
Avg vol (10-day) 32.87M
Shares outstanding 5199.46M
Implied shares outstanding 6N/A
Float 8199.45M
% held by insiders 10.43%
% held by institutions 122.67%
Shares short (12 May 2022) 413.25M
Short ratio (12 May 2022) 41.83
Short % of float (12 May 2022) 46.64%
Short % of shares outstanding (12 May 2022) 46.64%
Shares short (prior month 13 Apr 2022) 49.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 244.53%
Operating margin (ttm)-156.67%

Management effectiveness

Return on assets (ttm)-10.56%
Return on equity (ttm)59.72%

Income statement

Revenue (ttm)22.23M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)1.23M
EBITDA -34.77M
Net income avi to common (ttm)54.37M
Diluted EPS (ttm)0.2820
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)169.79M
Total cash per share (mrq)0.85
Total debt (mrq)100k
Total debt/equity (mrq)0.06
Current ratio (mrq)21.32
Book value per share (mrq)0.87

Cash flow statement

Operating cash flow (ttm)-43.25M
Levered free cash flow (ttm)-18.86M